323 related articles for article (PubMed ID: 2659501)
1. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
Mayumi H; Good RA
Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
[TBL] [Abstract][Full Text] [Related]
3. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
Mayumi H; Good RA
Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
Mayumi H; Good RA
J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel method to induce tolerance in adult mice across fully allogeneic (entire H-2 plus multiminor histocompatibility) antigen barriers, using supralethal irradiation followed by injection of syngeneic bone marrow cells plus (donor X recipient) F1 spleen cells.
Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
Immunobiology; 1989 Jun; 179(2-3):214-29. PubMed ID: 2793203
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance.
Tomita Y; Nomoto K
Immunobiology; 1990 Nov; 181(4-5):430-7. PubMed ID: 2099910
[TBL] [Abstract][Full Text] [Related]
7. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
[TBL] [Abstract][Full Text] [Related]
8. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K
J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906
[TBL] [Abstract][Full Text] [Related]
9. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
[TBL] [Abstract][Full Text] [Related]
11. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
12. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice.
Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K
Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598
[TBL] [Abstract][Full Text] [Related]
14. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
[TBL] [Abstract][Full Text] [Related]
15. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
[TBL] [Abstract][Full Text] [Related]
16. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced tolerance in fully allogeneic heart transplantation in mice.
Matsuura A; Katsuno M; Suzuki Y; Ito T; Yasuura K; Abe T; Yoshikai Y
Cell Immunol; 1994 May; 155(2):501-7. PubMed ID: 8181080
[TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
19. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients.
Mayumi H; Himeno K; Tanaka K; Tokuda N; Fan JL; Nomoto K
Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
